Change from baseline mean daily use of β2‐agonists (puffs/day) (duration 24 to 44 weeks) · people with asthma
1 finding from 1 review
Dyspnea · cervical spinal cord injury
1 finding from 1 review
Vital capacity · cervical spinal cord injury
1 finding from 1 review
Maximum inspiratory pressure · cervical spinal cord injury
1 finding from 1 review
Maximum expiratory pressure · cervical spinal cord injury
1 finding from 1 review
FEV1 · cervical spinal cord injury
1 finding from 1 review
Quality of life · cervical spinal cord injury
1 finding from 1 review
Respiratory complications · cervical spinal cord injury
1 finding from 1 review
Word retrieval · adults with primary progressive aphasia (PPA)
1 finding from 1 review
no estimate extracted
1 study · 3 participants
Very low
Overall language abilities · adults with primary progressive aphasia (PPA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function · adults with primary progressive aphasia (PPA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · adults with primary progressive aphasia (PPA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · adults with primary progressive aphasia (PPA)
1 finding from 1 review
no estimate extracted
1 study · 3 participants
Very low
Participant‐perceived cure after treatment · women with SUI
Pelvic floor muscle training leads to higher participant‐perceived cure after treatment Treatment duration: 3–6… compared with control (high certainty).
1 finding from 1 review
Short (up to 1 hour) pad test measured as grams of urine Treatment duration: 6 weeks to 6 months · women with UI (all types)
1 finding from 1 review
GRADE A UI‐specific symptom measures Treatment duration: 12 weeks · women with UI (all types)
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Moderate
GRADE A UI‐specific QoL measures Treatment duration: 6–12 weeks · women with UI (all types)
1 finding from 1 review
Participant‐perceived cure after treatment · UUI in women
1 finding from 1 review
Participant‐reported cure or improvement: immediately after treatment · UUI in women
1 finding from 1 review
Episodes of urinary incontinence in a 24‐hour period · UUI in women
1 finding from 1 review